MMSET is highly expressed and associated with aggressiveness in neuroblastoma

Cancer Research

Volumn 71, Issue 12, 2011, Pages 4226-4235

  Hudlebusch, Heidi Rye ^a   Skotte, Julie ^a   Santoni Rugiu, Eric ^b   Zimling, Zarah Glad ^b   Lees, Michael James ^a   Simon, Ronald ^e   Sauter, Guido ^e   Rota, Rossella ^f   De Ioris, Maria Antonietta ^f   Quarto, Micaela ^g   Johansen, Jens Vilstrup ^a   Jørgensen, Mette ^a   Rechnitzer, Catherine ^c   Maroun, Lisa Leth ^b   Schrøder, Henrik ^d   Petersen, Bodil Laub ^b   Helin, Kristian ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

^c University of Copenhagen   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^g FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BRAIN DERIVED NEUROTROPHIC FACTOR; HISTONE LYSINE METHYLTRANSFERASE; MMSET PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FEMALE; GANGLIONEUROMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFANT; MALE; METASTASIS POTENTIAL; MOUSE; NEURAL STEM CELL; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN TARGETING; STEM CELL; TISSUE MICROARRAY; TUMOR BIOPSY;

CELL DIFFERENTIATION; CELL PROLIFERATION; GENES, MYC; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; NEURAL STEM CELLS; NEUROBLASTOMA; PROGNOSIS; REPRESSOR PROTEINS;

EID: 79958845131     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-3810     Document Type: Article

References (32)

1. Zimling ZG, Rechnitzer C, Rasmussen M, Petersen BL. Peripheral neuroblastic tumours in eastern Denmark 1972-2002. APMIS 2007;115:66-74.
2. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer 1999;86:349-63. (Pubitemid 29327593)
3. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 1999;86:364-72. (Pubitemid 29327594)
4. Franks LM, Bollen A, Seeger RC, Stram DO, Matthay KK. Neuroblastoma in adults and adolescents: an indolent course with poor survival. Cancer 1997;79:2028-35. (Pubitemid 27200389)
5. Janoueix-Lerosey I, Lequin D, Brugieres L, Ribeiro A, de Pontual L, Combaret V, et al. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature 2008;455:967-70.
6. Mosse YP, Laudenslager M, Longo L, Cole KA, Wood A, Attiyeh EF, et al. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 2008;455:930-5.
7. Bown N. Neuroblastoma tumour genetics: clinical and biological aspects. J Clin Pathol 2001;54:897-910. (Pubitemid 34032883)
8. Nimura K, Ura K, Shiratori H, Ikawa M, Okabe M, Schwartz RJ, et al. A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome. Nature 2009;460:287-91.
9. Li Y, Trojer P, Xu CF, Cheung P, Kuo A, Drury WJ III, et al. The target of the NSD family of histone lysine methyl transferases depends on the nature of the substrate. J Biol Chem 2009;284:34283-95.
10. Chesi M, Nardini E, Lim RS, Smith KD, Kuehl WM, Bergsagel PL. The t (4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts. Blood 1998;92:3025-34. (Pubitemid 28492306)
11. Garlisi CG, Uss AS, Xiao H, Tian F, Sheridan KE, Wang L, et al. A unique mRNA initiated within a middle intron of WHSC1/MMSET encodes a DNA binding protein that suppresses human IL-5 transcription. Am J Respir Cell Mol Biol 2001;24:90-8. (Pubitemid 32097512)
12. Kim JY, Kee HJ, Choe NW, Kim SM, Eom GH, Baek HJ, et al. Multiplemyeloma- related WHSC1/MMSET isoform RE-IIBP is a histone methyltransferase with transcriptional repression activity. Mol Cell Biol 2008;28:2023-34.
13. Stec I, Wright TJ, van Ommen GJ, de Boer PA, van Haeringen A, Moorman AF, et al. WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. Hum Mol Genet 1998;7:1071-82. (Pubitemid 28306870)
14. Keats JJ, Reiman T, Maxwell CA, Taylor BJ, Larratt LM, Mant MJ, et al. In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression. Blood 2003;101:1520-9.
15. Rasmussen T, Hudlebusch HR, Knudsen LM, Johnsen HE. FGFR3 dysregulation in multiple myeloma: frequency and prognostic relevance. Br J Haematol 2002;117:626-8. (Pubitemid 34539238)
16. Avet-Loiseau H, Facon T, Grosbois B, Magrangeas F, Rapp MJ, Harousseau JL, et al. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. Blood 2002;99:2185-91. (Pubitemid 34525505)
17. Fonseca R, Blood E, Rue M, Harrington D, Oken MM, Kyle RA, et al. Clinical and biologic implications of recurrent genomic aberrations in myeloma. Blood 2003;101:4569-75. (Pubitemid 36857829)
18. Lauring J, Abukhdeir AM, Konishi H, Garay JP, Gustin JP, Wang Q, et al. The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity. Blood 2008;111:856-64.
19. Marango J, Shimoyama M, Nishio H, Meyer JA, Min DJ, Sirulnik A, et al. The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor. Blood 2008;111:3145-54.
20. Brito JL, Walker B, Jenner M, Dickens NJ, Brown NJ, Ross FM, et al. MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells. Haematologica 2009; 94:78-86.
21. Li J, Yin C, Okamoto H, Mushlin H, Balgley BM, Lee CS, et al. Identification of a novel proliferation-related protein, WHSC1 4a, in human gliomas. Neuro Oncol 2008;10:45-51. (Pubitemid 351250899)
22. Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 2001; 61:2129-37. (Pubitemid 32692038)
23. Kassambara A, Klein B, Moreaux J. MMSET is overexpressed in cancers: link with tumor aggressiveness. Biochem Biophys Res Commun 2009;379:840-5.
24. Hudlebusch HR, Santoni-Rugiu E, Simon R, Ralfskiaer E, Rossing HH, Johansen JV, et al. The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors. Clin Cancer Res 2011;17:2919-33.
25. Encinas M, Iglesias M, Liu Y, Wang H, Muhaisen A, Cena V, et al. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem 2000;75:991-1003. (Pubitemid 30660487)
26. Bibel M, Richter J, Lacroix E, Barde YA. Generation of a defined and uniform population of CNS progenitors and neurons from mouse embryonic stem cells. Nat Protoc 2007;2:1034-43. (Pubitemid 46901284)
27. Simon R, Sauter G. Tissue microarrays for miniaturized high-throughput molecular profiling of tumors. Exp Hematol 2002;30:1365-72. (Pubitemid 35449792)
28. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984;224:1121-4. (Pubitemid 14106392)
29. Lonergan GJ, Schwab CM, Suarez ES, Carlson CL. Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. Radiographics 2002;22:911-34.
30. Bibel M, Richter J, Schrenk K, Tucker KL, Staiger V, Korte M, et al. Differentiation of mouse embryonic stem cells into a defined neuronal lineage. Nat Neurosci 2004;7:1003-9. (Pubitemid 39129511)
31. Encinas M, Iglesias M, Llecha N, Comella JX. Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y. J Neurochem 1999;73: 1409-21. (Pubitemid 29440140)
32. Hudlebusch HR, Theilgaard-Monch K, Lodahl M, Johnsen HE, Rasmussen T. Identification of ID-1 as a potential target gene of MMSET in multiple myeloma. Br J Haematol 2005;130:700-8. (Pubitemid 43906642)